Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry [0.03%]
托伐普坦治疗常染色体显性多囊肾病患者8年的加拿大真实世界评价:C-MAJOR注册研究
Philip McFarlane,Daniel G Bichet,Ahsan Alam et al.
Philip McFarlane et al.
Background: Tolvaptan is the only approved treatment in Canada for slowing the progression of kidney enlargement and kidney function decline in people with autosomal dominant polycystic kidney disease (ADPKD). The Canadia...
Characterizing the Experiences and Educational Needs of Patients and Caregivers During the Kidney Transplant Process [0.03%]
肾移植过程中心脏病患者和护理人员的经历及教育需求的描述
Michelle Ruhl,Ashley Burghall,Brianna Groot et al.
Michelle Ruhl et al.
Background: Kidney transplantation, a life-saving therapy for children with kidney disease, remains challenging to navigate for patients and families. Obj...
Guillaume Soret,Antonio Leidi,Thomas A Mavrakanas
Guillaume Soret
Postoperative Bilateral Renal Cortical Necrosis Secondary to Antiphospholipid Syndrome: A Case Report and Literature Review [0.03%]
抗磷脂综合征继发术后双侧肾皮质坏死一例及相关文献复习
Sara S Jdiaa,Carmen Avila-Casado,Jorge Sanchez-Guerrero et al.
Sara S Jdiaa et al.
We report a case of biopsy-proven renal cortical necrosis in a 42-year-old man after bioprosthetic aortic valve replacement despite prophylactic anticoagulation. He had antiphospholipid syndrome with chronic thrombotic microangiopathy and t...
Benefits and Challenges When Implementing Incremental Hemodialysis: A Qualitative Study of Patients and Providers [0.03%]
增量透析的利弊及实施中的挑战——一项针对患者和医师的质性研究
Noémie Laurier,Chloe Wong-Mersereau,Shaifali Sandal et al.
Noémie Laurier et al.
Background: In 2022, we implemented an incremental hemodialysis (iHD) protocol to initiate twice-weekly treatment for eligible patients. This patient-centered approach aims to ease the transition to dialysis and enhance q...
Establishing a National Quality Improvement Program for Nephrology Fellows: The Canadian Society of Nephrology Experience [0.03%]
建立全国性的肾脏病学质控改善项目——加拿大肾脏病学会经验报告
Jordan Thorne,Samuel A Silver,Daniel Blum et al.
Jordan Thorne et al.
Purpose of program: In 2021, the Canadian Society of Nephrology (CSN) sent a needs assessment survey to nephrology residents, fellows, and program directors that identified a significant gap in Quality Improvement (QI) tr...
Prevalence of Chronic Kidney Disease in Latin America: A Systematic Review and Meta-analysis [0.03%]
拉美慢性肾脏病患病率的系统评价和meta分析
Víctor Juan Vera-Ponce,Joan A Loayza-Castro,Luisa Erika Milagros Vásquez-Romero et al.
Víctor Juan Vera-Ponce et al.
Background: Chronic kidney disease (CKD) represents a global health concern, with particular significance in Latin America due to socioeconomic inequalities and heterogeneous health care systems. ...
Outcomes of Adopting a Higher Versus Lower Concentration of Hemodialysate Magnesium as a Center-Wide Policy (Dial-Mag): A Clinical Research Protocol of a Pragmatic, Registry-Based, Cluster Randomized Trial [0.03%]
高浓度与低浓度透析液镁中心政策的结局:一项务实的、基于登记的分层随机试验临床研究方案(Dial-Mag)
Dial-Mag Investigator Writing Committee*;Lauren Killin,Clara Bohm,Claire Harris et al.
Dial-Mag Investigator Writing Committee*;Lauren Killin et al.
Background: In individuals receiving hemodialysis, lower serum magnesium concentrations are associated with a higher risk of death and cardiovascular disease and more discomfort from muscle cramps. Small trials suggest th...
Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Prescribed SGLT2 Inhibitors in British Columbia: A Single-Arm Retrospective Cohort Study [0.03%]
BC遗传性多囊肾病患者使用SGLT2抑制剂的结局:单组回顾性队列研究
Alessandro Cau,Mark Elliott,Adeera Levin et al.
Alessandro Cau et al.
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the fourth leading cause of kidney failure in Canada and internationally. To date, patients with ADPKD have been excluded from trials of sodium-glucose c...
Proactive Prescription-Based Fluid Management Versus Usual Care in Critically Ill Patients on Kidney Replacement Therapy (Probe-Fluid): A Pilot Clinical Trial Protocol [0.03%]
基于处方的前瞻性液体管理与重症肾替代治疗患者的常规护理的比较(Probe-Fluid):一项临床试验方案
Alicia Shen,Josée Bouchard,Javier A Neyra et al.
Alicia Shen et al.
Background: Severe acute kidney injury (AKI) in the intensive care unit (ICU) is complicated by fluid accumulation, making fluid removal a central component of kidney replacement therapy (KRT). However, the optimal fluid ...